phically determined thyroid volume had decreased, but there was still abnormalities by ultrasound detected in 14/36 patients; 19.4% had focal sonolucent lesions, whereas the prevalence of such lesions was only 3.1% in asymptomatic controls. Three patients were subclinically hypothyroid at the follow-up, whereas all others were euthyroid. Patients with abnormal ultrasound findings were of the same age and had a similar thyroid size, but a slightly higher TSH and a significantly (P<0.02) lower free T4 than those with normal ultrasound findings. They also had a higher prevalence of thyroid autoantibodies in low titres. Serum thyroglobulin was elevated in more than half of the patients during the acute phase, but only in 1 out of 11 patients during follow-up. Thyroglobulin at the follow-up was not related to TSH, but there was a correlation with thyroid volume (r = 0.57). In The prevalence of abnormal US findings in these patients was compared with results of a field study conducted in 666 asymptomatic subjects which has been published in detail elsewhere (Olbricht et al. 1983a Volumetry: during SAT, mean thyroid volume was 20.3 ± 10.2 ml in 12 patients, 6 had goitres (>20 ml). At follow-up, thyroid volume was 11.7 ± 7.1 ml in 36 patients, and only 3 had volumes >20 ml (8.3%). Ten patients had volumetry per¬ formed both during the acute phase and at followup. In these patients, mean thyroid volume de¬ creased from 20 ± 11.2 to 11.9 ± 8.0 ml (Fig. 2) .
In the field study of 666 subjects, the prevalence of goitre was 10.8%, and the prevalence of focal changes within normally sized glands was 4.2%. (Smallridgeetal. 1986 ).
